Eli Lilly and Company NYQ · LLY

IHE vs IXJ: Which Popular Healthcare ETF Is the Better Buy for Investors?

The Motley Fool · 4h ago

The Most Overlooked Reason Eli Lilly Stock Keeps Surging -- and It Has Nothing to Do With Weight Loss

The Motley Fool · 1d ago

Wegovy Pill Just Changed the GLP-1 Market. Here's Why Eli Lilly Stock Could Still Win

The Motley Fool · 1d ago

Atlas Healthcare Fund by VST Capital Entered Eli Lilly at $350 in 2020 — The Stock Now Trades Above $1,200

GlobeNewswire Inc. · 1d ago

Why AtaiBeckley Stock Soared Today

The Motley Fool · 2d ago

Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETF

The Motley Fool · 2d ago

Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider

GlobeNewswire Inc. · 3d ago

3 Vanguard ETFs Poised to Outperform as the Market Shifts Beyond Big Tech

The Motley Fool · 3d ago

Oral Obesity Therapies Market to Reach $6.32 Billion by 2030 as Demand for GLP-1 Treatments Accelerates

GlobeNewswire Inc. · 3d ago

Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market?

The Motley Fool · 4d ago

Here's How Much Eli Lilly's Weight-Loss Drugs Are Worth to Investors

The Motley Fool · 5d ago

3 Dividend Stocks That Are No-Brainer Buys Heading Into the Second Half of 2026

The Motley Fool · 7d ago

History Says Doing This 1 Thing Will Score You an Investing Win -- Even After a Market Crash.

The Motley Fool · 7d ago

Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?

The Motley Fool · 9d ago

Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026?

The Motley Fool · 10d ago

Is It Too Late to Buy Eli Lilly?

The Motley Fool · 10d ago

Prediction: Eli Lilly Stock Will Hit This Price by the End of 2026

The Motley Fool · 10d ago

BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?

The Motley Fool · 10d ago

Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom

The Motley Fool · 11d ago

Hims & Hers Pullback Could Create a Better Entry Into GLP-1 Demand

Investing.com · 11d ago

Is It Too Late to Buy Eli Lilly Stock? Here's What $1,000 Invested Today Could Be Worth in 10 Years.

The Motley Fool · 11d ago

Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

The Motley Fool · 12d ago

Could This Healthcare Stock Help You Build a Real Fortune Over the Next 20 Years?

The Motley Fool · 12d ago

Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida

GlobeNewswire Inc. · 12d ago

Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best?

The Motley Fool · 13d ago